Clinical and biochemical footprints of inherited metabolic diseases. II. Metabolic liver diseases
Inherited metabolic diseases account for about one third of pediatric patients with hepatomegaly, acute liver failure, cirrhosis or cholestasis. Specifically for pediatric acute liver failure, they account for 10–15% of cases, with a mortality of 22–65%. The percentage of acute liver failure caused...
Saved in:
Published in: | Molecular genetics and metabolism 2019-06, Vol.127 (2), p.117-121 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | eng |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Inherited metabolic diseases account for about one third of pediatric patients with hepatomegaly, acute liver failure, cirrhosis or cholestasis. Specifically for pediatric acute liver failure, they account for 10–15% of cases, with a mortality of 22–65%. The percentage of acute liver failure caused by an inherited metabolic disease in children |
---|---|
ISSN: | 1096-7192 1096-7206 |